Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes

Stem Cells

Volumn 26, Issue 1, 2008, Pages 244-253

  Urbán, Veronika S ^a   Kiss, Judit ^a   Kovács, János ^b   Gócza, Elen ^c   Vas, Virág ^a   Monostori, Eva ^d   Uher, Ferenc ^a  

^a NATIONAL MEDICAL CENTER   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c SZENT ISTVÁN UNIVERSITY   (Hungary)

^d INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Bone marrow; Diabetes; Immunosuppression; Mesenchymal stem cells; Streptozotocin; Transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL REGENERATION; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; INSULIN BLOOD LEVEL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; STREPTOZOCIN DIABETES; T LYMPHOCYTE; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; T-LYMPHOCYTES;

ANIMALIA; MUS;

EID: 38349062691     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0267     Document Type: Article

References (55)

1. Nir T, Dor Y. How to make pancreatic beta cells - Prospects for cell therapy in diabetes. Curr Opin Biotechnol 2005;16:524 -529.
2. Madsen OD. Stem cells and diabetes treatment. APMIS 2005;113:858-875.
3. Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003;21:763-770.
4. Ianus A, Holz GG, Theise ND et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:843-850.
5. Mathews V, Hanson PT, Ford E et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004;53:91-98.
6. Lechner A, Yang YG, Blacken RA et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004;53:616-623.
7. Banerjee M, Kumar A, Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 2005;328:318-325.
8. Zorina TD, Subbotin VM, Bertera S et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. STEM CELLS 2003;21:377-388.
9. Kang EM, Zickler PP, Burns S et al. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp Hematol 2005;33:699-705.
10. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006;103:17438-17443.
11. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus. Science 1976;193:415-417.
12. Paik SG, Fleischer N, Shin SI. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: Obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci U S A 1980;77:6129-6133.
13. Hadjantonakis AK, Gertsenstein M, Ikawa M et al. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 1998;76:79-90.
14. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
15. Horwitz MS, Ilic A, Fine C et al. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 2002;109:79-87.
16. Albera C, Polak JM, Janes S et al. Repopulation of human pulmonary epithelium by bone marrow cells: A potential means to promote repair. Tissue Eng 2005;11:1115-1121.
17. Caplan AI. Review: Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics. Tissue Eng 2005;11:1198-1211.
18. Krabbe C, Zimmer J, Meyer M. Neural transdifferentiation of mesenchymal stem cells - A critical review. APMIS 2005;113:831-844.
19. Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease [Review]. Exp Biol Med (Maywood) 2006;231:39-49.
20. Rojas M, Xu J, Woods CR et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
21. Wilson GL, Leiter EH. Streptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes. Curr Top Microbiol Immunol 1990;156:27-54.
22. Ihm SH, Lee KU, Rhee BD et al. Initial role of macrophage in the development of anti-beta-cell cellular autoimmunity in multiple low-dose streptozotocin-induced diabetes in mice. Diabetes Res Clin Pract 1990;10:123-126.
23. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res 2006;312:2169-2179.
24. Krampera M, Pasini A, Pizzolo G et al. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol 2006;6:435-441.
25. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
26. Choi JB, Uchino H, Azuma K et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003;46:1366-1374.
27. Pasquali L, Fan Y, Trucco M et al. Rehabilitation of adaptive immunity and regeneration of beta cells. Trends Biotechnol 2006;24:516-522.
28. Dor Y. Beta-cell proliferation is the major source of new pancreatic beta cells. Nat Clin Pract Endocrinol Metab 2006;2:242-243.
29. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 2004;114:963-968.
30. Seaberg RM, Smukler SR, Kieffer TJ et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004;22:1115-1124.
31. Suzuki A, Nakauchi H, Taniguchi H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 2004;53:2143-2152.
32. Abraham EJ, Kodama S, Lin JC et al. Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathol 2004;164:817-830.
33. Ta M, Choi Y, Atouf F et al. The defined combination of growth factors controls generation of long-term-replicating islet progenitor-like cells from cultures of adult mouse pancreas. STEM CELLS 2006;24:1738-1749.
34. Hao E, Tyrberg B, Itkin-Ansari P et al. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 2006;12:310-316.
35. Izumida Y, Aoki T, Yasuda D et al. Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells. Biochem Biophys Res Commun 2005;333:273-282.
36. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001;294:564-567.
37. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084.
38. Bunnell BA, Deng W, Robinson CM et al. Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases. Can J Physiol Pharmacol 2005;83:529-539.
39. Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 2005;100:471-481.
40. Bang OY, Lee JS, Lee PH et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57:874-882.
41. Rasmusson I, Ringden O, Sundberg B et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005;305:33-41.
42. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
43. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
44. Deng W, Han Q, Liao L et al. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 2005;24:458-463.
45. Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006;36:2566-2573.
46. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321-334.
47. Kodama S, Kuhtreiber W, Fujimura S et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003;302:1223-1227.
48. Chong AS, Shen J, Tao J et al. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 2006;311:1774-1775.
49. Nishio J, Gaglia JL, Turvey SE et al. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 2006;311:1775-1778.
50. Suri A, Calderon B, Esparza TJ et al. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 2006;311:1778-1780.
51. Perone MJ, Bertera S, Tawadrous ZS et al. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J Immunol 2006;177:5278-5289.
52. Herold KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002;346:1692-1698.
53. Keymeulen B, Vandemeulebroucke E, Ziegler AG et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005;352:2598-2608.
54. Min DI, Monaco AP. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy 1991;11:119S-125S.
55. Rezzani R. Cyclosporine A and adverse effects on organs: Histochemical studies. Prog Histochem Cytochem 2004;39:85-128.